Yuv Glim MP 1mg/500mg/15mg Tablet SR
Marketer
All Molecules
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Yuv Glim MP 1mg/500mg/15mg Tablet SR
Glimepiride/Metformin/Pioglitazone extended-release tablets (1mg/500mg/15mg) are a triple-combination medication designed to manage elevated blood glucose. This treatment, used alongside a healthy diet and regular exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness, consequently reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Take this medication with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly; however, if your next dose is imminent, omit the missed dose and resume your regular schedule. Never double the dose. Overdosage may result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals can increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Kidney function tests will be performed prior to treatment initiation. Limit alcohol consumption as it may potentiate adverse reactions.
Uses of Yuv Glim MP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Yuv Glim MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Yuv Glim MP 1mg/500mg/15mg Extended-Release Tablet should be administered with a meal.
Common Side effects of Yuv Glim MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Yuv Glim MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Yuv Glim MP 1mg/500mg/15mg Extended-Release Tablet should be administered with a meal.
How Yuv Glim MP 1mg/500mg/15mg Tablet SR works:
Yuv Glim MP Tablet SR (1mg/500mg/15mg) combines glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts via multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Yuv Glim MP 1mg/500mg/15mg SR tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
Using Yuv Glim MP 1mg/500mg/15mg SR tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Yuv Glim MP 1mg/500mg/15mg tablet may pose a risk to breastfeeding infants. Available human evidence indicates potential transfer to breast milk and subsequent infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Yuv Glim MP 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is necessary. This medication is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Yuv Glim MP 1mg/500mg/15mg Tablet SR; dosage modification may be necessary. Consult a physician for guidance. The use of Yuv Glim MP 1mg/500mg/15mg Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Yuv Glim MP 1mg/500mg/15mg Tablet SR :
Should you forget to take a Yuv Glim MP 1mg/500mg/15mg Tablet SR, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Yuv Glim MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently